Trump’s Price Gouging Pivot: From “Communist” Label to Policy U-Turn
Stephen Miller’s past criticisms of government intervention in drug pricing, including referring to such policies as “communist” and labeling Kamala Harris as “Comrade Kamala,” have resurfaced following President Trump’s executive order implementing “Most Favored Nation” pricing. This policy, which aims to drastically lower prescription drug costs by referencing prices in other countries, directly contradicts Miller’s previously stated positions. Miller’s silence on the order is notable given his outspoken opposition to similar Democratic proposals. The stark contrast highlights the inherent irony of the Trump administration’s expansion of government influence in the pharmaceutical sector.
John Q. Hosedrinker